Qube Research & Technologies (QRT)’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,600	Closed	-$12.5K	–	3908
2024 Q3	$12.5K	Buy	+21,600	New	+$12.1K	﹤0.01%	3012
2023 Q2	–	Sell	-212,837	Closed	-$592K	–	3149
2023 Q1	$592K	Buy	212,837 +105,960	+99%	+$303K	﹤0.01%	1507
2022 Q4	$369K	Buy	106,877 +76,686	+254%	+$219K	﹤0.01%	1587
2022 Q3	$78K	Buy	+30,191	New	+$96.1K	﹤0.01%	2044
2022 Q2	–	Sell	-243,786	Closed	-$1M	–	3249
2022 Q1	$1M	Buy	+243,786	New	+$1.29M	0.01%	1169
2021 Q2	–	Sell	-69,995	Closed	-$660K	–	2899
2021 Q1	$660K	Buy	+69,995	New	+$964K	0.01%	1024

Other funds holding GRTS

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GRTS Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 21,600 shares — an estimated $12.5K sold.

Qube Research & Technologies (QRT) first reported a position in GRTS in Q1 2021 and held it in 6 quarters. The position peaked at $1M in Q1 2022. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

Qube Research & Technologies (QRT) reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 21,600 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $12.5K.
Qube Research & Technologies (QRT) first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Gritstone bio, Inc. Common Stock position peaked at $1M in Q1 2022.
6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.